Our Centres

One of the most rewarding outcomes of ASIG’s activities has been the improvement in the quality of care ASIG centres can deliver for people living with scleroderma. Most centres have expanded the services they offer to include specialist nurses and have become centres of excellence. This growth in patient numbers and experience has led to a number of centres being invited to participate in industry-funded clinical trials, allowing patients to have access to new therapies for the first time in many years.
The Canberra Hospital

The Canberra Hospital

The Rheumatology Unit in Canberra has a long and productive history having started in 1976 with the appointment of Dr Andrew Brook. It has steadily grown since then and is currently staffed by 5 part time rheumatologists including Clinical A/Professor Kathleen Tymms, Dr Anna Dorai Raj, Dr Ted Tsai, Dr Peta Pentony and Dr Katie Morrisroe as well as2 fulltime rheumatologists Dr Kokum Dissanayake and Dr Chandi Perera, the Unit Director.

The department has a strong focus on clinical service delivery, supporting rheumatology patients within the ACT and surrounding regional areas, undergraduate and postgraduate teaching, and research activities with links to the John Curtin School of Medical Research and the ANU Medical School.

It is supported by 2 advanced trainee registrars, JMO, Rheumatology Advanced Practice Nurse, Rheumatology Registered Nurse, Rheumatology Office Manager and Rheumatology Administrative Staff Member.

Referrals to Canberra Hospital should be addressed to:
A/Prof Kathie Tymms, Dr Kathleen Morrisroe

Rheumatology Department, Canberra Hospital Rheumatology Department, Garran, ACT 2605

Tel: 02 6124 3789 / 02 5124 3107

Fax: 02 5124 5894

Email: [email protected]

Royal Hobart Hospital

Royal Hobart Hospital

Tel: 03 6266 8308

John Hunter Hospital

John Hunter Hospital

Dr Gabor Major is Director of rheumatology at the Hunter New England Health Service. He is a member of the Australian Scleroderma Interest Group (ASIG) and conducts clinics at The John Hunter Hospital in Newcastle, New South Wales.

Fiona Niddrie, Rheumatology Clinical Nurse Consultant, co-ordinates and maintains the ASIG screening program.

Professor Glenn Reeves is convener of the monthly multidisciplinary clinic held at the John Hunter hospital for the management of patients with pulmonary hypertension. The clinic is attended by consultants from cardiology, respiratory, rheumatology and immunology and is a teaching opportunity for basic and advanced trainees. 

Shelley Dunlap, Clinical Nurse Specialist, coordinates all patient referrals and assists with assessment and applications for required medications.

Referrals to John Hunter Hospital should be addressed to:

Dr Gabor Major

Dept of Rheumatology Royal Newcastle Centre / John Hunter Hospital, Lookout Rd, New Lambton Heights 2305

Tel: 02 4922 3500

Fax: 02 4922 3562

Email (JHH central referral management):
[email protected]

From Left: Professor Glenn Reeve (PAH), Shelley Dunlap (PAH), Fiona Niddrie (ASIG), Dr Gabor Major (ASIG)
Monash Scleroderma Clinic

Monash Scleroderma Clinic

The Monash Scleroderma Clinic has been running since 2003 at Clinic M, Monash Health in Clayton. We see about 380 patients with Scleroderma, providing clinical and wound care as well as annual screening for heart and lung complications of Scleroderma. Patients are seen in a bulk billing clinic with a referral from their GP and can access screening with lung function tests and echocardiogram (heart ultrasound) which can usually be performed on the same day as clinic appointments.

Our Scleroderma nurse attends each clinic to provide education, support, advice and assistance with wound care for patients. Patients requiring further cardiac or respiratory assessment can be referred to our onsite cardiologist, Dr  Roger Peverill and Respiratory physician Dr Chris Daley who form part of our team. Patients with foot ulcers can also be referred to and co-managed at the Monash High Risk Foot Clinic where they are seen by a multidisciplinary team which includes a podiatrist experienced in managing Scleroderma related foot problems. Patients attending our clinic can choose to enrol in the Australian Scleroderma Cohort Study.  This study is a longitudinal study involving patients from a number of centres around Australia which has facilitated improvement in our understanding of Scleroderma and its treatment. Participation is voluntary and involves answering some additional questions and providing some additional blood samples once a year.

At Monash, our particular interest has been in the cardiac and pulmonary complications of Scleroderma. Ongoing research interest include identification of predictors of progression of Scleroderma related lung fibrosis and defining the effect of Scleroderma on cardiac structure and function. The Monash Scleroderma clinic has also collaborated with an experienced team of scientists on site in the Monash Centre of Inflammatory diseases to undertake lab based research to advance our understanding of the disease mechanisms underlying Scleroderma. Monash also has a clinical trials unit which enrols patients in studies examining new treatments which may provide benefit beyond our existing treatment options.

Referrals to the Monash Scleroderma clinic should be addressed to:

Professor Eric Morand, Monash Rheumatology

Monash Health , Block E, Level 3, 246 Clayton Rd Clayton 3168

Tel: 03 9594 4899

Preferred means of referral. Fax: 03 9554 9200

Email: [email protected]

A/Prof Joanne Sahhar

Adj. Clinical Associate Professor
Adj. Clinical Assoc. Prof. Joanne Sahhar heads the scleroderma team at Monash Health. She has a longstanding interest in the care of patients with scleroderma and research in scleroderma having developed the first Victorian scleroderma database in 1999 and founded the Monash scleroderma clinic in 2003. She has been an active member of ASIG since its inception in 2007 as a member of the executive, scientific and database committees. She is passionate about advancing research in Scleroderma to improve outcomes for patients with Scleroderma and has a particular interest in scleroderma Interstitial Lung disease (ILD). She also works in private practice in Toorak.

Dr Diane Apostolopoulos

Rheumatologist
Dr Diane Apostolopoulos is a rheumatologist who is part of the scleroderma team at Monash Health. She also has a public appointment at the Northern Hospital and works in private practice in Heidelberg. After completing rheumatology advanced training, she commenced a PhD through Monash University and is currently in the final stages of completion.

Dr Gene-Siew Ngian

Rheumatologist
Dr Gene-Siew Ngian is a rheumatologist who is part of the scleroderma team at Monash Health. She also has an appointment at the Royal Melbourne Hospital and works in private practice in inner Melbourne. After her rheumatology advanced training, she undertook a PhD at the University of Melbourne examining the cardiovascular manifestations of scleroderma and remains active in clinical research.
Fiona Stanley Hospital Scleroderma Clinic

Fiona Stanley Hospital Scleroderma Clinic

The Scleroderma clinic at Fiona Stanley Hospital in Western Australia is a weekly clinic taking place in the outpatient’s area within the hospital. Presently, the clinic manages over 300 patients with scleroderma and connective tissue diseases per year. The scleroderma team at Fiona Stanley Hospital comprises consultant rheumatologists, Dr Janet Roddy and Dr Lauren Host, clinical nurse Helen Marsden, rheumatology and basic physician trainees. We are privileged to work closely with consultant respiratory physician Dr Melanie Lavender and her team in the Advanced Lung Disease Unit, plastic surgeon Dr Sharon Chu and her team in the hand clinic. Working closely with Dr Lavender and Dr Chu allows us to provide a truly multi-disciplinary approach to our patients with complicated cardiorespiratory disease and severe digital ulcers respectively. Running in parallel to the scleroderma clinic we have a digital ulcer service comprising a nurse led “drop in” clinic for all of our patients providing an invaluable service for those who have digital ulcers that need immediate attention. Research areas of special interest in WA include the use of ultrasound to measure skin thickness, investigation and treatment of digital ulcers in scleroderma patients, and at present we are reviewing our experience of using rituximab in scleroderma patients with interstitial lung disease.

Dr Janet Roddy

Rheumatologist
Dr Roddy has been an active member of ASIG since it was established in 2007, which has provided the opportunity for clinical research and national and international collaboration resulting in numerous publications and presentations. She has been involved in numerous pharmaceutical studies including being the principal investigator in two international multi-centre studies assessing drugs in skin progression. Dr Roddy looks forward to continuing to provide high quality care to scleroderma patients, providing trainees and students with an opportunity to learn about scleroderma and ongoing research collaboration opportunities.

Dr Lauren Host

Rheumatologist
Dr Lauren Host trained in Perth Western Australia, graduating with a Bachelor of Medicine, Bachelor of surgery from the University of Western Australia with Honours in 2009. Dr Host started her advanced training in Rheumatology in 2015. In 2017 she was awarded the Ken Muirden Overseas Training Fellowship, as well as the Australian Rheumatology Association Western Australia Training/Research fellowship. Between 2017 and 2018 Dr Host’s interest in Scleroderma led her to undertake a fellowship in Scleroderma and connective tissue diseases under the guidance of Professor Christopher Denton, at the Royal Free Hospital in London. During her time at the Royal Free Hospital, Dr Host engaged in both basic science and clinical research resulting in several presentations at national and international conferences, and publications. In 2017 Dr Host was admitted to Fellowship of the Royal Australasian College of Physicians as a Specialist Rheumatologist. In 2018 Dr Host worked as a locum rheumatology consultant at the Royal Free Hospital and continued her work and research in Scleroderma. That same year she became a scientific member of the ASIG. Dr Host returned to Perth in 2019 to take up a position as a consultant rheumatologist at Fiona Stanley and Royal Perth Hospitals. She continues research in scleroderma and her involvement in ASIG. Dr Host’s vision is to grow and improve the connective tissue disease service at Fiona Stanley Hospital via high quality research, training of junior doctors and engaging a multidisciplinary team.

Dr Sharon Chu

Plastic and Reconstructive Surgeon

Helen Marsden

Rheumatology nurse
Helen trained in Pontefract West Yorkshire, England, qualifying in 1988 as an RGN and following 12 years ward based experience on medical wards with rheumatology and dermatology patients went on to specialise in rheumatology nursing from 1999 within the Mid Yorkshire NHS Hospitals Trust. Helen completed a UKCC course in the management of Rheumatoid arthritis in 2000 and went on to achieve a Master’s degree through Huddersfield University in Advancing Clinical Practice based in Rheumatology in 2004 and a Clinical Nurse Independent Prescribing Module in 2006. In 2009 Helen joined the rheumatology team in Perth and has worked with the scleroderma clinic. Helen specialises in patient education and support, and the management of digital ulcers as well as database management and developed the weekly drop in Digital Ulcer Dressing Clinic for Scleroderma patients in 2017 as a rapid access, assessment and management clinic for digital ulcer patients. This has developed to include a once monthly multi-disciplinary team clinic with the Plastics service and hand therapy team.

Dr Janet Roddy

Rheumatologist
Dr Roddy has been an active member of ASIG since it was established in 2007, which has provided the opportunity for clinical research and national and international collaboration resulting in numerous publications and presentations. She has been involved in numerous pharmaceutical studies including being the principal investigator in two international multi-centre studies assessing drugs in skin progression. Dr Roddy looks forward to continuing to provide high quality care to scleroderma patients, providing trainees and students with an opportunity to learn about scleroderma and ongoing research collaboration opportunities.

Dr Lauren Host

Rheumatologist
Dr Lauren Host trained in Perth Western Australia, graduating with a Bachelor of Medicine, Bachelor of surgery from the University of Western Australia with Honours in 2009. Dr Host started her advanced training in Rheumatology in 2015. In 2017 she was awarded the Ken Muirden Overseas Training Fellowship, as well as the Australian Rheumatology Association Western Australia Training/Research fellowship. Between 2017 and 2018 Dr Host’s interest in Scleroderma led her to undertake a fellowship in Scleroderma and connective tissue diseases under the guidance of Professor Christopher Denton, at the Royal Free Hospital in London. During her time at the Royal Free Hospital, Dr Host engaged in both basic science and clinical research resulting in several presentations at national and international conferences, and publications. In 2017 Dr Host was admitted to Fellowship of the Royal Australasian College of Physicians as a Specialist Rheumatologist. In 2018 Dr Host worked as a locum rheumatology consultant at the Royal Free Hospital and continued her work and research in Scleroderma. That same year she became a scientific member of the ASIG. Dr Host returned to Perth in 2019 to take up a position as a consultant rheumatologist at Fiona Stanley and Royal Perth Hospitals. She continues research in scleroderma and her involvement in ASIG. Dr Host’s vision is to grow and improve the connective tissue disease service at Fiona Stanley Hospital via high quality research, training of junior doctors and engaging a multidisciplinary team.

Dr Sharon Chu

Plastic and Reconstructive Surgeon

Helen Marsden

Rheumatology nurse
Helen trained in Pontefract West Yorkshire, England, qualifying in 1988 as an RGN and following 12 years ward based experience on medical wards with rheumatology and dermatology patients went on to specialise in rheumatology nursing from 1999 within the Mid Yorkshire NHS Hospitals Trust. Helen completed a UKCC course in the management of Rheumatoid arthritis in 2000 and went on to achieve a Master’s degree through Huddersfield University in Advancing Clinical Practice based in Rheumatology in 2004 and a Clinical Nurse Independent Prescribing Module in 2006. In 2009 Helen joined the rheumatology team in Perth and has worked with the scleroderma clinic. Helen specialises in patient education and support, and the management of digital ulcers as well as database management and developed the weekly drop in Digital Ulcer Dressing Clinic for Scleroderma patients in 2017 as a rapid access, assessment and management clinic for digital ulcer patients. This has developed to include a once monthly multi-disciplinary team clinic with the Plastics service and hand therapy team.

Royal Adelaide Hospital

Royal Adelaide Hospital

A scleroderma outpatient service was established at the Royal Adelaide Hospital in 2007 by Professor Susanna Proudman who was the inaugural Chair of the Australian Scleroderma Interest Group (ASIG). It is now located in the new Royal Adelaide Hospital, which lies within Adelaide’s Biomed City at the western end of the city. A dedicated scleroderma clinic is conducted weekly in the Outpatient Department Service where patients receive care for the full range of scleroderma disease features. All are assessed annually for pulmonary arterial hypertension (PAH). Some are referred to this clinic only for this annual assessment and continue to receive care from their private rheumatologist or specialist physician between visits. We are also fortunate to be able to offer a second rheumatology clinic held fortnightly with A/Professor Jenny Walker, a senior rheumatologist from the Flinders Medical Centre with expertise in scleroderma. Patients attending these clinics with ongoing scleroderma-related issues such as digital ulcers and PAH receive specialist nursing care including assessment, treatment advice and education from our rheumatology nurse practitioner Leah McWilliams. We work closely with cardiology and respiratory colleagues to access specialist assessment and care when needed. These clinics are highly valued by the doctors in training, comprising an advanced trainee in rheumatology and a basic physician trainee, who work in the Rheumatology Unit. These potential rheumatologists of the future appreciate the opportunity to learn about scleroderma from the patients themselves. All patients are offered the opportunity to participate in the Australian Scleroderma Cohort Study and contribute to ASIG’s research activities. Approximately 300 have been recruited from the RAH to date.

The Royal Adelaide Hospital Rheumatology Research Unit is managed by a Senior Medical Scientist. Together with other research staff, they work closely with Prof Proudman to afford our patients access to best practice evidence-based care and contemporary research. Dr Mahin Moghaddami is a basic scientist who manages the ASIG biobank housed in the University of South Australia’s Cancer Research Institute also located within Adelaide’s Biomed City. A select few patients seize the opportunity when approached to enrol in rheumatology research clinical trials expertly coordinated by Ms Cindy Hall which are often in collaboration with our extraordinary rheumatology colleagues across Australia.

Address referral to Professor Susanna Proudman, Head Rheumatology Unit and send to the Referral Management Hub:

Tel: 08 7074 1239

Fax: 08 7074 6247

Email: [email protected]

Prof Susanna Proudman

Medical Director
Susanna Proudman is Director of the Rheumatology Unit at the Royal Adelaide Hospital. As the immediate past Chair of the Australian Scleroderma Interest Group, she established the Australian Scleroderma Cohort Study in 2007 which has led to collaborations with national and international colleagues such as the International Systemic Sclerosis Inception Cohort (INSYNC). Her research interests include “best practice” management of early rheumatoid arthritis with an emphasis on “treat-to-target” therapy and the role of omega-3 fatty acids and standardised management of systemic sclerosis and pulmonary arterial hypertension. She is Medical Director of Arthritis Australia.

A/Prof Jenny Walker

Associate Professor
Associate Professor Jenny Walker is a staff specialist at the Flinders Medical Centre and she also undertakes a dedicated scleroderma clinic at the Royal Adelaide Hospital. She became a fellow of the Royal Australasian College of Physicians in 2003 and completed her PhD in 2005. In 2006 she was awarded the RACP Australian Rheumatology fellowship and commenced a post-doctoral clinical and research fellowship in Calgary, Canada. Here she worked with Canadian Scleroderma Research Group. She is a member of the scientific committee of the Australian Scleroderma Interest Group (ASIG) and has a particular interest in the clinical significance of the autoantibody profile in scleroderma. Her other research interests include intracellular signalling in rheumatoid arthritis and the down titration of targeted therapies in inflammatory arthritis.

Leah McWilliams

Nurse Practitioner
Leah provides our patients attending clinics with ongoing scleroderma-related issues such as digital ulcers and PAH with specialist nursing care including assessment, treatment advice and education.

Prof Susanna Proudman

Medical Director
Susanna Proudman is Director of the Rheumatology Unit at the Royal Adelaide Hospital. As the immediate past Chair of the Australian Scleroderma Interest Group, she established the Australian Scleroderma Cohort Study in 2007 which has led to collaborations with national and international colleagues such as the International Systemic Sclerosis Inception Cohort (INSYNC). Her research interests include “best practice” management of early rheumatoid arthritis with an emphasis on “treat-to-target” therapy and the role of omega-3 fatty acids and standardised management of systemic sclerosis and pulmonary arterial hypertension. She is Medical Director of Arthritis Australia.

A/Prof Jenny Walker

Associate Professor
Associate Professor Jenny Walker is a staff specialist at the Flinders Medical Centre and she also undertakes a dedicated scleroderma clinic at the Royal Adelaide Hospital. She became a fellow of the Royal Australasian College of Physicians in 2003 and completed her PhD in 2005. In 2006 she was awarded the RACP Australian Rheumatology fellowship and commenced a post-doctoral clinical and research fellowship in Calgary, Canada. Here she worked with Canadian Scleroderma Research Group. She is a member of the scientific committee of the Australian Scleroderma Interest Group (ASIG) and has a particular interest in the clinical significance of the autoantibody profile in scleroderma. Her other research interests include intracellular signalling in rheumatoid arthritis and the down titration of targeted therapies in inflammatory arthritis.

Leah McWilliams

Nurse Practitioner
Leah provides our patients attending clinics with ongoing scleroderma-related issues such as digital ulcers and PAH with specialist nursing care including assessment, treatment advice and education.
Royal Prince Alfred Hospital, Institute of Rheumatology and Orthopaedics

Royal Prince Alfred Hospital, Institute of Rheumatology and Orthopaedics

This study is being run by the Department of Rheumatology at the Institute of Rheumatology and Orthopaedics (IRO), which is located in the Queen Elizabeth 2 building of Royal Prince Alfred Hospital. The IRO is comprised of rheumatologists, nurses, allied health professionals and supporting consultants who care for patients with bone, joint and connective tissue diseases.

Referrals to Royal Prince Alfred Hospital should be addressed to:

Prof Peter Youssef

Royal Prince Alfred Hospital, Rheumatology Department, Level 4, Queen Elizabeth II Building, 59 Missenden Road, Camperdown NSW 2050

Tel: 02 9515 9337

Fax: 02 9515 9466

A/Prof Peter Youssef

Associate Investigator
Prof Youssef is a Senior Staff Specialist at Royal Prince Alfred Hospital and Clinical Professor of Rheumatology at Sydney University. He became a fellow of the Royal Australasian College of Physicians in 1993, and completed his doctorate in 1997 at the Flinders University of South Australia. Since 2007 he has been the rheumatology subeditor of the Internal Medicine Journal and Chair of the Scientific Advisory Board of Arthritis Australia. He has been the Chair of the Scientific Committee of the Australian Scleroderma Interest Group and the Scientific Programs Committee of the Australian Rheumatology Association. He is currently on the board of the OPAL group. He is a member of the European Synovitis Study Group. He currently serves on the RPAH drug committee.

His major interests are in rheumatoid arthritis (particularly the causes of damage and the role of targeted therapies) and systemic sclerosis, particularly screening for pulmonary hypertension and the role of autologous stem cell transplants. He has received NHMRC project funding and is currently involved in studies of rheumatoid arthritis, psoriatic arthritis, systemic sclerosis, ankylosing spondylitis and myositis.

Dr Matthew Parker

Associate Investigator
Dr Parker is a Staff Specialist in Rheumatology and Clinical Lecturer at the University of Sydney. He also helps provide regular specialist services to rural central NSW. He was the recipient of the Leanne Stafford Award in 2017/18 which enabled his Fellowship in the UK prior to taking up his position at RPAH.
He is an investigator in a number of ongoing clinical trials. He is working to develop a more integrated neuromuscular service for patients with suspected inflammatory myopathies, including setting up a registry and biobank for patients with these conditions, and will be enrolling in a part time PhD to further his research interests. His major clinical and research interests are inflammatory muscle disease, connective tissue disease-associated interstitial lung disease and nailfold capillaroscopy.

Dr Angela Fu

Associate Investigator
Dr Fu is a Staff Specialist in Rheumatology at Royal Prince Alfred Hospital. She became a fellow of the Royal Australasian College of Physicians in 2003. She has been actively involved in a number of clinical studies of gout, rheumatoid arthritis and systemic sclerosis. Dr Fu is also a guest speaker on the SBS radio program and conducts patient education seminars for Arthritis NSW, Lupus Association, Parramatta City Council and the Australian Chinese Medical Association.


Dr Tamera Corte

Associate Investigator
A/Prof Corte is a Consultant Respiratory Physician and Director of Interstitial Lung Disease in the Department of Respiratory Medicine at Royal Prince Alfred Hospital, an Associate Professor at the University of Sydney and is the Chair of the Steering Committee for the Australian Idiopathic Pulmonary Fibrosis Registry and a member of multiple international task forces for interstitial lung disease guidelines.
A/Prof Corte trained in respiratory medicine at the University of New South Wales in Sydney, Australia. She served as Clinical Fellow in Interstitial Lung Disease at the Royal Brompton Hospital in London with Professor Athol Wells. Dr Corte earned a doctor of philosophy degree in the identification of pulmonary vascular dysfunction in interstitial lung disease. She continues her research at Sydney University, where her interests include interstitial lung diseases as well as pulmonary vascular disease.

A/Prof Peter Youssef

Associate Investigator
Prof Youssef is a Senior Staff Specialist at Royal Prince Alfred Hospital and Clinical Professor of Rheumatology at Sydney University. He became a fellow of the Royal Australasian College of Physicians in 1993, and completed his doctorate in 1997 at the Flinders University of South Australia. Since 2007 he has been the rheumatology subeditor of the Internal Medicine Journal and Chair of the Scientific Advisory Board of Arthritis Australia. He has been the Chair of the Scientific Committee of the Australian Scleroderma Interest Group and the Scientific Programs Committee of the Australian Rheumatology Association. He is currently on the board of the OPAL group. He is a member of the European Synovitis Study Group. He currently serves on the RPAH drug committee.

His major interests are in rheumatoid arthritis (particularly the causes of damage and the role of targeted therapies) and systemic sclerosis, particularly screening for pulmonary hypertension and the role of autologous stem cell transplants. He has received NHMRC project funding and is currently involved in studies of rheumatoid arthritis, psoriatic arthritis, systemic sclerosis, ankylosing spondylitis and myositis.

Dr Matthew Parker

Associate Investigator
Dr Parker is a Staff Specialist in Rheumatology and Clinical Lecturer at the University of Sydney. He also helps provide regular specialist services to rural central NSW. He was the recipient of the Leanne Stafford Award in 2017/18 which enabled his Fellowship in the UK prior to taking up his position at RPAH.
He is an investigator in a number of ongoing clinical trials. He is working to develop a more integrated neuromuscular service for patients with suspected inflammatory myopathies, including setting up a registry and biobank for patients with these conditions, and will be enrolling in a part time PhD to further his research interests. His major clinical and research interests are inflammatory muscle disease, connective tissue disease-associated interstitial lung disease and nailfold capillaroscopy.

Dr Angela Fu

Associate Investigator
Dr Fu is a Staff Specialist in Rheumatology at Royal Prince Alfred Hospital. She became a fellow of the Royal Australasian College of Physicians in 2003. She has been actively involved in a number of clinical studies of gout, rheumatoid arthritis and systemic sclerosis. Dr Fu is also a guest speaker on the SBS radio program and conducts patient education seminars for Arthritis NSW, Lupus Association, Parramatta City Council and the Australian Chinese Medical Association.


Dr Tamera Corte

Associate Investigator
A/Prof Corte is a Consultant Respiratory Physician and Director of Interstitial Lung Disease in the Department of Respiratory Medicine at Royal Prince Alfred Hospital, an Associate Professor at the University of Sydney and is the Chair of the Steering Committee for the Australian Idiopathic Pulmonary Fibrosis Registry and a member of multiple international task forces for interstitial lung disease guidelines.
A/Prof Corte trained in respiratory medicine at the University of New South Wales in Sydney, Australia. She served as Clinical Fellow in Interstitial Lung Disease at the Royal Brompton Hospital in London with Professor Athol Wells. Dr Corte earned a doctor of philosophy degree in the identification of pulmonary vascular dysfunction in interstitial lung disease. She continues her research at Sydney University, where her interests include interstitial lung diseases as well as pulmonary vascular disease.

St. Vincent’s Hospital Melbourne – Rheumatology

St. Vincent’s Hospital Melbourne – Rheumatology

Located in Fitzroy in central Melbourne, St. Vincent’s Hospital Melbourne is one of the founding sites of the Australian Scleroderma Cohort Study, with patients attending St. Vincent’s Rheumatology Clinics being a part of the study since 2007. Over 500 scleroderma patients in the Australian Scleroderma Cohort Study (ASCS) have been recruited from St. Vincent’s, where they attend their yearly review and receive regular scleroderma care. The ASIG database is managed out of the St. Vincent’s Hospital Melbourne Department of Rheumatology. Our unit has long had a special interest in all aspect of management and assessment of  cardiopulmonary complications especially PAH and ILD.  We have a strong commitment to clinical trials in all aspects of scleroderma. In particular, over the last 10 years we have been involved in novel treatments for digital ulcers, Diffuse skin disease, Pulmonary hypertension and interstitial lung disease. The unit has recently acquired a 200 fold nailfold capillaroscopy unit and has an interest in using this in the diagnosis of very early Scleroderma.  A recent research project has looked at patterns of nailfold abnormalities as predictor of digital ulcer and other organ feature. This is an area of ongoing interest.

Referrals to St. Vincent's Hospital Melbourne should be addressed to:

Dr Wendy Stevens/ Dr Mandana Nikpour/ Dr Nava Ferdowsi/ Dr Laura Ross

Department of Rheumatology, St Vincent’s Hospital Melbourne, 41 Victoria Parade, Fitzroy

Tel: 03 9288 3983

Fax: 03 9288 3841

Dr Wendy Stevens

Rheumatologist
Dr Wendy Stevens is a consultant rheumatologist and clinical investigator. After completing her FRACP training in Australia in 1987, she spent 18 months in London as registrar to Dame Professor Carol Black, a world-renowned expert in systemic sclerosis (SSc). In this position she gained extensive experience and expertise in managing patients with SSc. Since 1989, she has held the position of Consultant Rheumatologist at St Vincent’s Hospital Melbourne and heads the Scleroderma clinic at this hospital. She has a strong interest in clinical trials and novel therapies for scleroderma and pulmonary hypertension and a research interest in nail fold capillaroscopy

A/Prof Mandana Nikpour

Rheumatologist
A/Prof Mandana Nikpour MBBS FRACP FRCPA PhD, is a rheumatologist at St. Vincent’s Hospital Melbourne, and a NHMRC Emerging Leadership Fellow at the University of Melbourne. Her research interests include risk and prognostic factors for cardiopulmonary and other clinically important outcomes in systemic sclerosis and systemic lupus erythematosus, development of clinical tools for screening and prediction of outcome, measurement of disease activity and damage, and clinical trials of novel therapies in the rheumatic diseases. She has over 150 peer-reviewed publications and leads several international working groups and research consortia in systemic autoimmune diseases. As the Chair of the Australian Scleroderma Interest Group (ASIG), A/Prof Nikpour and her team were awarded the 2018 Australian Rheumatology Association (ARA) collaborative research prize. A/Prof Nikpour was awarded the ARA Parr Prize, a once per career award, for her research contributions in rheumatology.

Dr Nava Ferdowsi

Rheumatologist
It was after completing her Rheumatology training at St Vincent's Hospital, Melbourne, that Nava's interest in looking after patients with Scleroderma was sparked. She went on to complete a post graduate Masters degree researching Scleroderma patients under the supervision of Associate Professor Mandana Nikpour and Dr Wendy Stevens, and has since remained involved with research and patient care.

Dr Kathleen (Katie) Morrisroe

Rheumatologist
Dr Katie Morrisroe is a Melbourne trained rheumatologist who completed her medical degree at Monash University, specialist rheumatology fellowship at St Vincent’s Hospital and completed her PhD in systemic sclerosis (scleroderma) through the University of Melbourne. She continues to pursue her research into systemic sclerosis, having recently been awarded a NHMRC Investigator Grant, in addition to working as a clinical rheumatologist.

Dr Laura Ross

Staff Specialist in Rheumatology
Dr Ross is a Staff Specialist in Rheumatology at St Vincent’s Hospital, Melbourne and a PhD Candidate at the University of Melbourne, under the supervision of A/Prof Mandana Nikpour. Dr Ross works in the Scleroderma Clinic at St Vincent’s Hospital, Melbourne and is an active member in many of ASIG’s projects.
Dr Ross’ research interests are the development of outcome measures for use in clinical trials and cardiac disease in systemic sclerosis. The focus of her PhD is to develop an activity index for use in systemic sclerosis clinical trials which can be used to measure the efficacy of new therapies. Additionally, Dr Ross has been working to develop the first classification criteria for the diagnosis of systemic sclerosis heart involvement. Part of this work has included a collaboration with the Baker Heart and Diabetes Institute to quantify the burden of heart disease in systemic sclerosis.

Dr Zoe Brown

Rheumatologist
Dr Brown is a rheumatologist at St. Vincent’s Hospital Melbourne, a course coordinator for the University of Melbourne St. Vincent’s Hospital clinical school and is a member of the education subcommittee of the Pulmonary Hypertension Society of Australia and New Zealand. Dr Brown is currently serving as the Clinical Fellow in Scleroderma Research with the Australian Scleroderma Interest Group in order to completes a doctor of philosophy degree implementing screening for the earlier diagnosis of pulmonary arterial hypertension in patients with systemic sclerosis and investigating the role of risk stratification in the management of patients with pulmonary arterial hypertension.

Dr Wendy Stevens

Rheumatologist
Dr Wendy Stevens is a consultant rheumatologist and clinical investigator. After completing her FRACP training in Australia in 1987, she spent 18 months in London as registrar to Dame Professor Carol Black, a world-renowned expert in systemic sclerosis (SSc). In this position she gained extensive experience and expertise in managing patients with SSc. Since 1989, she has held the position of Consultant Rheumatologist at St Vincent’s Hospital Melbourne and heads the Scleroderma clinic at this hospital. She has a strong interest in clinical trials and novel therapies for scleroderma and pulmonary hypertension and a research interest in nail fold capillaroscopy

A/Prof Mandana Nikpour

Rheumatologist
A/Prof Mandana Nikpour MBBS FRACP FRCPA PhD, is a rheumatologist at St. Vincent’s Hospital Melbourne, and a NHMRC Emerging Leadership Fellow at the University of Melbourne. Her research interests include risk and prognostic factors for cardiopulmonary and other clinically important outcomes in systemic sclerosis and systemic lupus erythematosus, development of clinical tools for screening and prediction of outcome, measurement of disease activity and damage, and clinical trials of novel therapies in the rheumatic diseases. She has over 150 peer-reviewed publications and leads several international working groups and research consortia in systemic autoimmune diseases. As the Chair of the Australian Scleroderma Interest Group (ASIG), A/Prof Nikpour and her team were awarded the 2018 Australian Rheumatology Association (ARA) collaborative research prize. A/Prof Nikpour was awarded the ARA Parr Prize, a once per career award, for her research contributions in rheumatology.

Dr Nava Ferdowsi

Rheumatologist
It was after completing her Rheumatology training at St Vincent's Hospital, Melbourne, that Nava's interest in looking after patients with Scleroderma was sparked. She went on to complete a post graduate Masters degree researching Scleroderma patients under the supervision of Associate Professor Mandana Nikpour and Dr Wendy Stevens, and has since remained involved with research and patient care.

Dr Kathleen (Katie) Morrisroe

Rheumatologist
Dr Katie Morrisroe is a Melbourne trained rheumatologist who completed her medical degree at Monash University, specialist rheumatology fellowship at St Vincent’s Hospital and completed her PhD in systemic sclerosis (scleroderma) through the University of Melbourne. She continues to pursue her research into systemic sclerosis, having recently been awarded a NHMRC Investigator Grant, in addition to working as a clinical rheumatologist.

Dr Laura Ross

Staff Specialist in Rheumatology
Dr Ross is a Staff Specialist in Rheumatology at St Vincent’s Hospital, Melbourne and a PhD Candidate at the University of Melbourne, under the supervision of A/Prof Mandana Nikpour. Dr Ross works in the Scleroderma Clinic at St Vincent’s Hospital, Melbourne and is an active member in many of ASIG’s projects.
Dr Ross’ research interests are the development of outcome measures for use in clinical trials and cardiac disease in systemic sclerosis. The focus of her PhD is to develop an activity index for use in systemic sclerosis clinical trials which can be used to measure the efficacy of new therapies. Additionally, Dr Ross has been working to develop the first classification criteria for the diagnosis of systemic sclerosis heart involvement. Part of this work has included a collaboration with the Baker Heart and Diabetes Institute to quantify the burden of heart disease in systemic sclerosis.

Dr Zoe Brown

Rheumatologist
Dr Brown is a rheumatologist at St. Vincent’s Hospital Melbourne, a course coordinator for the University of Melbourne St. Vincent’s Hospital clinical school and is a member of the education subcommittee of the Pulmonary Hypertension Society of Australia and New Zealand. Dr Brown is currently serving as the Clinical Fellow in Scleroderma Research with the Australian Scleroderma Interest Group in order to completes a doctor of philosophy degree implementing screening for the earlier diagnosis of pulmonary arterial hypertension in patients with systemic sclerosis and investigating the role of risk stratification in the management of patients with pulmonary arterial hypertension.

Referrals to Barwon Rheumatology Service should be addressed to:

Dr Gemma Strickland

Barwon Rheumatology Service, 156-158 Bellerine Street, Geelong, 3220

Tel: 03 5222 4491

Fax: 03 5222 2024

Email: [email protected]

©2020 Australian Scleroderma Interest Group (ASIG), All rights reserved.

©2020 Australian Scleroderma Interest Group (ASIG), All rights reserved.